chr17-4945972-T-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 4P and 8B. PM1PM5BP4_ModerateBP6_ModerateBS2
The NM_005022.4(PFN1):c.351A>T(p.Glu117Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00108 in 1,613,184 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E117G) has been classified as Pathogenic.
Frequency
Consequence
NM_005022.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PFN1 | NM_005022.4 | c.351A>T | p.Glu117Asp | missense_variant | 3/3 | ENST00000225655.6 | NP_005013.1 | |
PFN1 | NM_001375991.1 | c.*435A>T | 3_prime_UTR_variant | 2/2 | NP_001362920.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PFN1 | ENST00000225655.6 | c.351A>T | p.Glu117Asp | missense_variant | 3/3 | 1 | NM_005022.4 | ENSP00000225655.5 | ||
PFN1 | ENST00000574872.1 | c.243A>T | p.Glu81Asp | missense_variant | 2/2 | 2 | ENSP00000465019.1 |
Frequencies
GnomAD3 genomes AF: 0.000559 AC: 85AN: 152084Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000481 AC: 121AN: 251480Hom.: 0 AF XY: 0.000530 AC XY: 72AN XY: 135916
GnomAD4 exome AF: 0.00114 AC: 1665AN: 1460982Hom.: 1 Cov.: 29 AF XY: 0.00107 AC XY: 781AN XY: 726858
GnomAD4 genome AF: 0.000558 AC: 85AN: 152202Hom.: 0 Cov.: 32 AF XY: 0.000524 AC XY: 39AN XY: 74406
ClinVar
Submissions by phenotype
Amyotrophic lateral sclerosis type 18 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | Aug 28, 2019 | A heterozygous in-frame deletion insertion variant was identified, NM_005022.3(PFN1):c.350_351delinsGT in exon 3 of 3 of the PFN1 gene. This in-frame deletion insertion is predicted to create a moderate amino acid change from a glutamic acid to a glycine at position 117 of the protein, NP_005013.1(PFN1):p.(Glu117Gly). The glutamic acid at this position has high conservation (100 vertebrates, UCSC) and is located within the profiling domain. This variant is seen in gnomAD as two independent missense variants at a frequency of 0.05% each (140 heterozygotes and 136 heterozygotes). The variant has been previously reported in patients with ALS and also in control populations. Recent publications have called this variant a risk factor (ClinVar, Wu, CH. et al. (2012), Yang, S. et al. (2013), Fratta, P. et al. (2014)). Additionally, conflicting functional evidence has been reported for this variant (Wu, CH. et al. (2012), Henty-Ridilla, JL. et al. (2018)). A different variant in the same codon resulting in a change to aspartic acid has also been reported as pathogenic in ALS (Yang, S. et al. (2013)). Based on information available at the time of curation, this variant has been classified as LIKELY BENIGN. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at